Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery

Journal of Drug Targeting

Volumn 20, Issue 10, 2012, Pages 897-905

  Nishimura, Yuya ^a   Ishii, Jun ^a   Okazaki, Fumiyoshi ^a   Ogino, Chiaki ^a   Kondo, Akihiko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Controlled release; drug delivery; drug targeting; Hepatitis B virus; in vitro model; liposomes; nanoparticles

Indexed keywords

BIO NANOCAPSULE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXOTOXIN; EXOTOXIN A; GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; NANOCAPSULE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL KILLING; CYTOTOXICITY; ENDOSOME; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENES, ERBB-2; HUMANS; LIPOSOMES; NANOSTRUCTURES;

EID: 84868354180     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.725404     Document Type: Article

References (17)

1. Allured VS, Collier RJ, Carroll SF, McKay DB. (1986). Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci USA, 83, 1320-1324. (Pubitemid 16016120)
2. Davison Z, de Blacquière GE, Westley BR, May FE. (2011). Insulinlike growth factor-dependent proliferation and survival of triplenegative breast cancer cells: implications for therapy. Neoplasia, 13, 504-515.
3. Jia LT, Zhang LH, Yu CJ, Zhao J, Xu YM, Gui JH, Jin M, Ji ZL, Wen WH, Wang CJ, Chen SY, Yang AG. (2003). Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3. Cancer Res, 63, 3257-3262. (Pubitemid 36735880)
4. Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. (2008). Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release, 126, 255-264.
5. Kasuya T, Jung J, Kadoya H, Matsuzaki T, Tatematsu K, Okajima T, Miyoshi E, Tanizawa K, Kuroda S. (2008). In vivo delivery of bionanocapsules displaying Phaseolus vulgaris agglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V. Hum Gene Ther, 19, 887-895.
6. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. (1992). Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem, 267, 1953-1961.
7. Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J. (2008). Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res, 14, 3840-3849.
8. McLarty K, Cornelissen B, Scollard DA, Done SJ, Chun K, Reilly RM. (2009). Associations between the uptake of 111In-DTPAtrastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts. Eur J Nucl Med Mol Imaging, 36, 81-93.
9. Nagai T. (2005). Drug discovery and innovative drug delivery research in new drug development. Pharm Tech Japan, 21, 1949-1951.
10. Oess S, Hildt E. (2000). Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther, 7, 750-758. (Pubitemid 30255756)
11. Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Höidén-Guthenberg I, Widström C, Carlsson J, Tolmachev V, Ståhl S, Nilsson FY. (2006). Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res, 66, 4339-4348.
12. Shishido T, Azumi Y, Nakanishi T, Umetsu M, Tanaka T, Ogino C, Fukuda H, Kondo A. (2009a). Biotinylated bionanocapsules for displaying diverse ligands toward cell-specific delivery. J Biochem, 146, 867-874.
13. Shishido T, Yonezawa D, Iwata K, Tanaka T, Ogino C, Fukuda H, Kondo A. (2009b). Construction of arginine-rich peptide displaying bionanocapsules. Bioorg Med Chem Lett, 19, 1473-1476.
14. Shishido T, Mieda H, Hwang SY, Nishimura Y, Tanaka T, Ogino C, Fukuda H, Kondo A. (2010). Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells. Bioorg Med Chem Lett, 20, 5726-5731.
15. Stoeckl L, Funk A, Kopitzki A, Brandenburg B, Oess S, Will H, Sirma H, Hildt E. (2006). Identification of a structural motif crucial for infectivity of hepatitis B viruses. Proc Natl Acad Sci USA, 103, 6730-6734.
16. Tabata T. (2006). Drug delivery system: Basic technology for biomedical research, medical treatment and health care. Biotechnol J, 6, 553-555.
17. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, Tanizawa K, Kuroda S. (2003). Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol, 21, 885-890. (Pubitemid 36936193)